A–C) SAT TSHB mRNA (A) and TSH protein levels in both cleared (B) and crude (C) SAT, according to TSH mRNA levels (n = 6). *P < 0.05 and **P < 0.01 vs. subjects with low AT TSHB mRNA. D) TSHB mRNA in blood, SAT, and VAT. *P < 0.05 vs.
TSHB mRNA in blood. E, F) Bivariate correlation between TSHB and HMGCR gene expression in both VAT (E) and SAT (F). G, H) Effects of statins treatment on SAT (G) and VAT (H) TSHB mRNA levels in cohort 1. **P < 0.01 vs. nontreated subjects.